The brief
- Motilal Oswal said rising outsourced-services demand could benefit Indegene
- Indegene shares rose 5% after the upgrade
- The upgrade supports sentiment on Indegene and Indian healthcare-services outsourcing
| Stock | Traded | That day | vs Nifty | Volume | Since |
|---|---|---|---|---|---|
| INDGN | Fri, 25 Sept | +2.5% | +2.2% | 3.3× | +2.5% · Nifty +0.3% |
✓ Classifier read this as positive; INDGN rose 2.2% against the Nifty on the day it traded.
Indegene analyst recommendations
Motilal Oswal upgraded Indegene and set a target price of ₹708, citing demand for outsourced services and its role with life sciences clients. Axis Direct initiated coverage with a buy recommendation and indicated 18% upside.
Friday, 25 September
- Motilal Oswal upgrades Indegene and sets ₹708 target